1302P Lorlatinib in patients with ALK+ NSCLC treated beyond initial disease progressionS-H.I. Ou,Ben Solomon,Alice T. Shaw,S. Gadgeel,Benjamin Besse,Ross A. Soo,Antonello Abbattista,Holger Thurm, F. Toffalorio,Robin Wiltshire,Alessandra BearzAnnals of Oncology(2020)引用 1|浏览31暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要